AC
EW icon

AKO Capital’s Edwards Lifesciences EW Stock Holding History

AKO Capital’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,260,704
Closed -$142M – 26
2020
Q1 		$142M Sell
2,260,704
-224,565
-9% -$16.2M 3% 15
2019
Q4 		$193M Buy
2,485,269
+554,772
+29% +$43.3M 4.16% 12
2019
Q3 		$142M Buy
1,930,497
+219,735
+13% +$15.4M 3.45% 17
2019
Q2 		$105M Buy
1,710,762
+335,709
+24% +$20.3M 2.68% 19
2019
Q1 		$87.7M Buy
1,375,053
+540,510
+65% +$30.8M 2.65% 19
2018
Q4 		$42.6M Buy
834,543
+181,107
+28% +$9.16M 1.92% 18
2018
Q3 		$37.9M Sell
653,436
-76,572
-10% -$3.75M 1.94% 19
2018
Q2 		$35.4M Buy
+730,008
New +$34.1M 1.92% 18

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

AKO Capital's EW Position: Q2 2020 in Review

AKO Capital sold out of Edwards Lifesciences (EW) in Q2 2020, closing a stake of 2,260,704 shares — an estimated $142M sold.

AKO Capital first reported a position in EW in Q2 2018 and held it in 8 quarters. The position peaked at $193M in Q4 2019. 1,047 funds tracked by Wall St. Rank hold EW as of Q2 2020.

  • AKO Capital reported no remaining Edwards Lifesciences position as of Q2 2020 after selling out during the quarter.
  • AKO Capital sold 2,260,704 Edwards Lifesciences shares in Q2 2020, an estimated $142M.
  • AKO Capital first reported a position in Edwards Lifesciences in Q2 2018 and held it in 8 quarters.
  • AKO Capital's Edwards Lifesciences position peaked at $193M in Q4 2019.
  • 1,047 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2020.

Based on AKO Capital's 13F filing for Q2 2020, filed 3 Aug 2020.